| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 02/10/1998 | US5716953 Modifiers of gastrin and cholecystokinins |
| 02/05/1998 | WO1998004583A1 Conformationally constrained backbone cyclized somatostatin analogs |
| 02/05/1998 | WO1997047744A3 T-cell selective interleukin-4 agonists |
| 02/05/1998 | DE4447715C2 Oestrogen compsn contg. 3-sulphamoyl:oxy-oestratriene cpd. |
| 02/05/1998 | DE4447714C2 Oestrogen compsn contg. 3-sulphamoyl:oxy-oestratriene cpd. |
| 02/04/1998 | EP0822200A1 Synthesis of analogs of PTH and PTrP |
| 02/04/1998 | EP0667856B1 Novel vitamin d analogues |
| 02/04/1998 | CN1172432A Method of decreasing serum calcium levels |
| 01/29/1998 | WO1998003511A1 New triazolopurines, method of preparing them and their use as drugs |
| 01/29/1998 | WO1998003473A1 Compounds with growth hormone releasing properties |
| 01/29/1998 | WO1998003059A1 Galanin |
| 01/29/1998 | DE19629378A1 Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Triazolopurine new, processes for their preparation and their use as medicaments |
| 01/29/1998 | CA2256736A1 New triazolopurines, method of preparing them and their use as drugs |
| 01/28/1998 | EP0821061A2 Calcitonin gene-related peptide receptor component factor (houdc44) |
| 01/28/1998 | EP0821006A2 Derivatives of insulin having enhanced zinc binding activity |
| 01/28/1998 | EP0641791B1 Novel benzothiophene derivative |
| 01/27/1998 | US5712264 17-spiromethylene steroids |
| 01/27/1998 | US5711944 Interferon polymer conjugates |
| 01/22/1998 | WO1998002159A1 Novel treatment of leptine resistance |
| 01/22/1998 | CA2260044A1 Novel treatment of leptine resistance |
| 01/21/1998 | EP0819687A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/21/1998 | EP0819686A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/21/1998 | CN1170719A Estrogenic agents |
| 01/20/1998 | US5710294 Treatment of malignant and other diseases characterized by proliferative growth of undifferentiated cells |
| 01/20/1998 | US5710247 Process and intermediates for the synthesis of LHRH antagonists |
| 01/20/1998 | US5710246 Coupling oligopeptides; deprotecting |
| 01/20/1998 | US5710142 Vitamin D analogues |
| 01/20/1998 | US5710024 Polynucleotides that encode the calcitonin gene-related peptide receptor coponent factor (HOUNDC44) |
| 01/20/1998 | US5709881 Tablet capsule or granule comprising desogestrel |
| 01/15/1998 | WO1998001417A1 Calcium receptor-active compounds |
| 01/15/1998 | WO1998001128A1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 01/15/1998 | CA2207141A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/15/1998 | CA2207083A1 Benzothiophene compounds, and uses and formulations thereof |
| 01/14/1998 | EP0817645A1 Method for treatment of benign prostatic hypertrophy |
| 01/14/1998 | EP0684825A4 Method of preventing or inhibiting fertilization. |
| 01/14/1998 | CN1170405A Aryl-and hetaryl-sulfonamide derivatives, their perparation and their use as endothelin antagonists |
| 01/14/1998 | CN1170359A Transdermal system for the simultaneous delivery of a number of active principles |
| 01/13/1998 | US5707829 DNA sequences and secreted proteins encoded thereby |
| 01/07/1998 | EP0815224A1 Receptor activation by gas6 |
| 01/07/1998 | EP0814846A1 Gene therapy by secretory gland expression |
| 01/07/1998 | CN1036920C Heterocycle-containing carbonic acid derivatives |
| 01/06/1998 | US5705654 Antiandrogens |
| 01/06/1998 | US5705494 Anti-estrogenic activity of IIβ-substituted-19-NOR Steroids |
| 12/31/1997 | WO1997049709A1 Androgen receptor modulator compounds and methods |
| 12/31/1997 | WO1997049707A1 Tricyclic benzazepine vasopressin antagonists |
| 12/31/1997 | WO1997049407A1 Progestogen-anti-progestogen regimens |
| 12/31/1997 | CN1036836C Method for preparing medicine for transcortical application contg. steroidhormonen |
| 12/31/1997 | CA2258885A1 Tricyclic benzazepine vasopressin antagonists |
| 12/31/1997 | CA2255863A1 Progestogen-anti-progestogen regimens |
| 12/30/1997 | US5703066 Treating gynecological disorders |
| 12/30/1997 | CA2142707C Benzo-fused lactams promote release of growth hormone |
| 12/29/1997 | EP0813414A1 Combination of bisphosphonates and growth hormone secretagogues |
| 12/24/1997 | WO1997048379A1 Nasal administration of desmopressin |
| 12/24/1997 | CN1168695A Inhibitor of stem cell proliferation and uses thereof |
| 12/24/1997 | CA2258552A1 Nasal administration of desmopressin |
| 12/18/1997 | WO1997047744A2 T-cell selective interleukin-4 agonists |
| 12/18/1997 | WO1997047612A1 Novel thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same |
| 12/18/1997 | WO1997047333A1 Novel devices for transdermal administering of trimegestone |
| 12/18/1997 | CA2257902A1 Novel devices for transdermal administering of trimegestone |
| 12/18/1997 | CA2257275A1 New substituded 2,4-thiazolidinedione derivatives, processes for producing them and pharmaceutical compositions containing them |
| 12/18/1997 | CA2256459A1 T-cell selective interleukin-4 agonists |
| 12/17/1997 | EP0812831A1 Benzimidazole derivatives and their use as corticotropin releasing factor antagonists |
| 12/17/1997 | EP0719277B1 Androstenones |
| 12/17/1997 | CN1036718C Method for preparing 19-demethyl steroid compound having thiocarbon chain at 11-beta position |
| 12/16/1997 | US5698522 6-position modified decapeptide LHRH antagonists |
| 12/16/1997 | US5698201 Method for treatment of antigenically modified polypeptides |
| 12/11/1997 | WO1997046671A1 Enhanced efficacy of liposomal antisense delivery |
| 12/11/1997 | CA2256456A1 Enhanced efficacy of liposomal antisense delivery |
| 12/10/1997 | EP0811064A2 Mpl ligand analogs |
| 12/10/1997 | CN1167438A Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies |
| 12/10/1997 | CN1036651C Method for prepn. of carbostyril derivatives |
| 12/09/1997 | US5696146 3-((2,2-disubstituted-1,3-benzodioxolan-5-yl)methylcarbonyl) indole derivatives; useful for treating acne vulgaris, alpecia, seborrhoea, female hirsutism, benign prostatic hypertrophy and male pattern baldness |
| 12/09/1997 | US5696086 Administering before or after chemotherapy to promote thrombocyte production, also kits |
| 12/04/1997 | WO1997045441A1 7α-(5-METHYLAMINOPENTYL)-ESTRATRIENES, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN SAID 7α-(5-METHYLAMINOPENTYL)-ESTRATRIENES AND USE THEREOF FOR PRODUCTION OF DRUGS |
| 12/04/1997 | WO1997045421A1 Oxocoumarin and barbituric acid derivates, their preparation and their use as ligand inhibitors of a corticotropin-releasing factor (crf) and/or a crf-binding protein complex |
| 12/04/1997 | WO1997037664A3 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders |
| 12/04/1997 | CA2256344A1 7.alpha.-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7.alpha.-(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents |
| 12/04/1997 | CA2254744A1 Oxocoumarin and barbituric acid derivates, their preparation and their use as ligand inhibitors of a corticotropin-releasing factor (crf) and/or a crf-binding protein complex |
| 12/03/1997 | EP0730651A4 Surface loop structural analogues of fibroblast growth factors |
| 12/02/1997 | US5693609 Antidiabetic agents; extended duration of action |
| 11/27/1997 | WO1997044352A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof |
| 11/27/1997 | WO1997044339A1 Antagonists of gonadotropin releasing hormone |
| 11/27/1997 | WO1997044321A1 Antagonists of gonadotropin releasing hormone |
| 11/27/1997 | WO1997044041A1 Antagonists of gonadotropin releasing hormone |
| 11/27/1997 | WO1997044037A1 Antagonists of gonadotropin releasing hormone |
| 11/27/1997 | DE19622457A1 7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln 7alpha- (5-Methylaminopentyl) -estratriene, processes for their preparation, pharmaceutical compositions containing these 7alpha- (5-Methylaminopentyl) -estratriene and their use for the preparation of medicaments |
| 11/27/1997 | CA2255888A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof |
| 11/27/1997 | CA2254974A1 Antagonists of gonadotropin releasing hormone |
| 11/27/1997 | CA2254769A1 Antagonists of gonadotropin releasing hormone |
| 11/27/1997 | CA2254768A1 Antagonists of gonadotropin releasing hormone |
| 11/27/1997 | CA2254756A1 Antagonists of gonadotropin releasing hormone |
| 11/26/1997 | EP0686037A4 Hormone replacement therapy |
| 11/26/1997 | CN1036521C Process for preparing ester of organic acid with alcohol derivatives of 19-norsteroids and their salts |
| 11/25/1997 | US5691353 Method of inhibiting aortal smooth muscle cell proliferation using naphthyl compounds |
| 11/25/1997 | US5691186 Filariid cysteine protease genes |
| 11/20/1997 | WO1997043278A1 Somatostatin agonists and antagonists |
| 11/13/1997 | WO1997041887A1 Treatment of partial growth hormone insensitivity syndrome |
| 11/13/1997 | WO1997041866A1 Improvement of implantation rates after in vitro fertilization |
| 11/13/1997 | WO1997024116A3 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
| 11/13/1997 | WO1996040048A3 Novel uses for thyroid hormones or thyroid hormone-like compounds |